Comunicati.net - Comunicati pubblicati - susan hill Comunicati.net - Comunicati pubblicati - susan hill Mon, 26 Aug 2019 08:08:16 +0200 Zend_Feed_Writer 1.12.20 (http://framework.zend.com) http://content.comunicati.net/utenti/24282/1 Global Coronary Stent Market Size, Share, Growth, Application Analysis, Trends and Forecast Report, 2018 to 2024 Thu, 22 Aug 2019 15:11:00 +0200 http://content.comunicati.net/comunicati/aziende/tecnologia/591514.html http://content.comunicati.net/comunicati/aziende/tecnologia/591514.html susan hill susan hill The global coronary stents market is expected to reach USD 15.18 billion by 2024, according to a new report by Grand View Research, Inc. Rising prevalence of coronary artery diseases, supportive government reforms and increasing awareness are contributing factors for lucrative growth of coronary stents

The latest treatments available in cardiac care are expected to increase the life span of the elderly population subset. This demographic is characterized with low immunity levels and are prone to chronic diseases including CVDs. Thus, increasing geriatric population is thereby considered as a high impact rendering driver for the growth of this industry over the forecast period.

The coronary stent market is driven by reimbursement coverage provided by the general public Center for Medicare & Medicaid Services (CMS) and private payers. The coverage is availed under national coverage determination for carotid artery stenting, including products and service provider. The providers require completing certain conditions for coverage, all facilities to be certified by CMS to perform CAS procedures.

Grasp advance knowledge on Global Coronary Stent Industry through in-depth research insights:
https://www.grandviewresearch.com/research-insights/coronary-stents-market-biodegradable-stents-expected-to-grow-progressively

Reimbursement of medical devices is limited to the developed regions of Asia Pacific. For instance, Japan’s National Health Insurance system provides reimbursement for all medical devices. However, some countries in the Asia Pacific region have no scope for reimbursement and the patients themselves incur the expenses while the unprivileged ones often forego treatment, thus restraining the growth of this vertical in certain countries.

Further key findings from the study suggest:

  • DES held lucrative share in 2015. Avoidance of complications, ease of procedures and comfort to the patient are factors responsible for increased usage rate.
  • BVS are anticipated to growth exponential over the forecast period due to the added advantages such as restoring vasomotor function, and fewer complications offered by the product.
  • North America held substantial share in global coronary stents market. Sophisticated healthcare system, well planned reimbursement program, high healthcare expenditure and large pool of target population are responsible for the region’s substantial share.
  • Asia Pacific is anticipated to exhibit lucrative growth over the forecast period. Economic developments and government reforms especially in countries like India and China are supporting the growth of this region. 

Grand View Research has segmented the coronary stents market on the basis of product and region:

Global Coronary Stents Product Outlook (Revenue, USD Million, 2013 - 2024)

  • Bare Metal Stents (BMS)
  • Drug Eluting Stents
    • Biodegradable
    • Non-Biodegradable
  • Bioresorbable Vascular Scaffold (BVS)

Coronary Stents Regional Outlook (Revenue, USD Million, 2013 - 2024)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • MEA
]]>
Atrial Fibrillation Market Size, Share, Growth, Trends and Forecast Report, 2014 to 2020 Thu, 22 Aug 2019 14:30:04 +0200 http://content.comunicati.net/comunicati/aziende/tecnologia/591499.html http://content.comunicati.net/comunicati/aziende/tecnologia/591499.html susan hill susan hill The global atrial fibrillation market is expected to reach USD 16.17 billion by 2020. Rising occurrence of strokes, brain damage and atrial fibrillation owing to blood clots along with an increasing geriatric population is expected to drive industry growth. Technological advancements in the field of microwave catheter ablation and radiofrequency along with rising occurrence of diseases caused by lifestyle habits such as drinking and smoking are further expected to fuel growth. Moreover, increasing demand for smaller cardiac incisions, minimally invasive procedures and small recovery time post-surgery are projected to bolster growth. Also, global aging population combined with the changes in lifestyle increasing the risks of obesity and high blood pressure is likely to drive demand.

Pharmacological products accounted for over 50% market share in 2013. Low prices of these products along with increasing use of anti-coagulants as an add-on therapy to non-pharmacological procedures are expected to drive demand.

North America accounted for over 40% of global revenue in 2013. High penetration of non-pharmacological procedure and sophisticated reimbursement frameworks has resulted in its substantial demand over the past few years. High patient awareness and healthcare expenditure levels also contributed significantly towards region growth.

Asia-Pacific is expected to witness substantial growth during the forecast period, growing at a CAGR of over 13% from 2015 to 2022. Rising demand for non-pharmacological treatments due to improvement in healthcare infrastructure, high disposable incomes, and growing patient awareness are a few factors accounting for its rapid growth.

Radiofrequency catheter ablation procedure segment is expected to be the fastest growing segment with a CAGR of over 12% over the forecast period. Technological advancements related to maneuverability which helps in making tight bends inside the heart, the optimal size of the lesion produced and lower time required to recover from of catheter ablation is expected to drive demand over the next seven years.

Maze surgery occupied the second largest share of non-pharmacological treatment market. It removes the need for life-long anti-coagulants based treatment while reducing the occurrence of strokes. Anti-coagulants held the dominant market share in pharmacological treatment market as it reduced the incidence of blood clots and strokes which in turn is likely to propel demand over the projected period.

Key industry players include Boston Scientific Corporation, St. Jude Medical Inc., Johnson & Johnson Ltd., Sanofi-Aventis, CardioFocus Inc., Boehringer Ingelheim GmbH, Bristol-Myers Squibb Corporation, Biosense Webster Inc., AtriCure Inc. and Endoscopic Technologies Inc. St. Jude Medical Inc. developed an Endosense’sTactiCath. The technology provides live feedback related to pressure applied during microwave catheter ablations and radiofrequency.

Grand View Research has segmented the global atrial fibrillation market on the basis of fields of procedures and region:

Atrial Fibrillation Procedures Outlook

  • Pharmacological Products
    • Anti-arrhythmic Drugs
    • Anti-coagulant Drugs
  • Non-Pharmacological Treatment
    • Catheter Ablation Procedures
  •  
    •  
      • Radiofrequency
      • HIFU
      • Cryoablation
      • Microwave
      • Laser
    • Maze Surgery
    • Electric Cardioversion

Atrial Fibrillation Regional Outlook

  • North America
  • Europe
  • Asia Pacific
  • RoW

Access full research report on global atrial fibrillation market: 

http://www.grandviewresearch.com/industry-analysis/atrial-fibrillation-treatment-industry

]]>
Global Personal Mobility Devices Market Size, Share, Growth and Trend Analysis Report, 2012 to 2020 Thu, 22 Aug 2019 13:56:46 +0200 http://content.comunicati.net/comunicati/aziende/tecnologia/591485.html http://content.comunicati.net/comunicati/aziende/tecnologia/591485.html susan hill susan hill Global personal mobility devices market is expected to reach USD 8.0 billion by 2020, according to a new study by Grand View Research, Inc. Increasing geriatric population base and prevalence of target diseases are some key factors expected to drive market growth during the forecast period. Aging heightens the susceptibility of a person towards developing target diseases such as osteoporosis and rheumatoid arthritis. Therefore, a growing geriatric population base is expected to widen the patient base for manufacturers. Additionally, presence of supportive government initiatives aimed at strengthening reimbursement frameworks and growing R&D investments for new product development is expected to propel market growth over the next six years.

Further key findings from the study suggest:

  • Wheelchairs were the largest selling product segment in 2013. Growing demand for powered wheelchairs especially in the developed countries is expected to drive segment growth during the forecast period.
  • Premium rollators are identified as the most lucrative segment of this market. Manufacturers of these rollators capitalize on the unmet needs of patients. Features such as enhanced height, ability to handle heavy weight patients, handle adjustment mechanism are expected to enhance penetration rates. The introduction of specialized devices such as rollators with laser attachment for patients suffering from Parkinson’s is also expected to drive segment growth during the forecast period. These devices are expected to witness a rapid rise in demand in developed markets with patients holding high disposable income and awareness levels.
  • North America was the most matured regional personal mobility devices market in 2013. The region was the largest revenue generating market, accounting for over 35.0% of revenue in the year. Presence of supportive government policies, sophisticated healthcare infrastructure and growing geriatric population base are some factors attributing to its large share.
  • Asia Pacific is expected to grow at a lucrative growth rate during the forecast period. This region, owing to a growing geriatric population base, increasing disposable income and awareness levels is expected to witness a rapid gain in demand over the next six years.
  • Some key players of the personal mobility devices market include Drive Medical Design & Manufacturing, Electric Mobility, Sunrise Medical, Pride mobility, Briggs Healthcare, Kaye Products, Nova, Patterson Medical, Eurovema AB, Graham-Field Health Products Incorporation, Invacare and TOPRO
  • Developing technologically advanced personal mobility devices via extensive R&D investments and entering into strategic alliances with buyers are some key sustainability strategies adopted by these market players. 

Grand View Research has segmented the global personal mobility devices market on the basis of product and region: 

Global Personal Mobility Devices Product Outlook (Revenue, USD Million, 2012 - 2020)

  • Wheelchairs
    • Manual
    • Power
  • Scooters
  • Mobility aids
    • Rollators
  •  
    •  
      • Low cost
      • Premium
    • Other Walking aids (canes, crutches, walkers) 

Personal Mobility Devices Regional Outlook (Revenue, USD Billion, 2012 - 2020)

  • North America
    • U.S.
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Austria
    • Switzerland
  • Asia Pacific
    • Japan
  • RoW

Access full research report on global personal mobility devices market: 

http://www.grandviewresearch.com/industry-analysis/personal-mobility-devices-market

]]>
Pharmacy Automation Devices Market Size, Share, Growth, Trends and Forecast Report, 2014 to 2020 Thu, 22 Aug 2019 12:19:12 +0200 http://content.comunicati.net/comunicati/aziende/tecnologia/591412.html http://content.comunicati.net/comunicati/aziende/tecnologia/591412.html susan hill susan hill Pharmacy automation involves automation and mechanization of tasks that include distribution and handling medication processes carried out in heath care centers and specialty pharmacy centers. The global pharmacy automation devices industry is projected to grow at a CAGR of 7.3% from 2014 to 2020 and reach over USD 8.99 billion.

Automation systems such as packaging and labeling systems, medication dispensing system, storage and retrieval systems, table-top counters and compounding systems are employed in order improve the efficacy of regular jobs within pharmacies. The market is expected to grow owing to features including system integration that increases productivity and time to clinicians for patient care, thereby lowering medication errors.

Rising demand for pharmaceutical products, progressively growing technology and demand for precise robotic equipment & tools to perform operations at a faster rate are expected to be the key factors for market growth. Untapped growth opportunities in countries such as Brazil, China, and India coupled with escalating demand for automation in pharmacy and healthcare operations is expected to drive growth over the forecast period.

The market was dominated by automated medication dispensing systems in 2013. It accounted for a share of over 47.8% owing to growing demand for accurate medication dispensing systems. Automated dispensing systems have the ability to reduce significantly error rates and the ability to dispense hands-free. They provide storage, recording of medication, distribution to resident care and computer controlled dispensation.

Automated compounding systems are anticipated to grow rapidly at a CAGR of 8.4% from 2014 to 2020 owing to an increasing demand for mixing of medication and substantial decrease in total time to complete a dose.

The existence of IT healthcare systems and high rate of penetration in healthcare and pharmaceutical units resulted in North America occupying the largest regional market in 2013. It accounted for about 54.8% of the market revenue. Increasing healthcare overheads and R&D relevant to pharmacy automation devices are few factors responsible for its market share.

Asia Pacific is likely to grow at a CAGR of over 9.0% during the forecast period and is the most lucrative regional markets majorly due to improving healthcare infrastructure in emerging economies of China and India. Easy access available to new entrants including multinational pharmaceutical companies and distributors in this region coupled with the introduction of healthcare reforms in these countries is expected to drive market growth.

Key industry players include AmerisourceBergen Corporation, CareFusion Corporation, Accu-Chart Healthcare, ForHealth Technologies, GSE Scale Systems, Fulcrum Inc,McKesson Corporation, Innovation PharmaAssist Robotics, Pearson Medical Technologies, Health Robotics SRL, Kirby Lester, MedDispence, Pyxis Pharmacy Automation Systems, Medacist, MTS Medication Technologies, OmnicellInc, Cerner Corporation, Rice Lake Weighing Systems, Baxter International Inc., Aesynt Inc., ScriptPro LLC, Parat Systems Pharmacy Automation, Yuyama Co. Ltd, Swisslog Holding Ltd,Talyst Inc. and ScriptPro LLC.

Grand View Research has segmented the pharmacy automation devices market on the basis of application, end-use and region:

Pharmacy Automation Devices Application Outlook

  • Automated Medication Dispensing Systems
  • Automated Packaging And Labeling Systems
  • Automated Storage And Retrieval Systems
  • Automated Medication Compounding Systems
  • Table Top Tablet Counters

Pharmacy Automation Devices End-use Outlook

  • Hospital Pharmacy
  • Retail Pharmacy

Pharmacy Automation Devices Regional Outlook

  • North America
  • Europe
  • Asia Pacific
  • RoW

Access full research report on global artificial pharmacy automation devices market: 

http://www.grandviewresearch.com/industry-analysis/pharmacy-automation-market

]]>
Artificial Pancreas Device System Market Size, Share, Growth and Trend Analysis Report, 2018 to 2024 Thu, 22 Aug 2019 11:57:15 +0200 http://content.comunicati.net/comunicati/aziende/tecnologia/591402.html http://content.comunicati.net/comunicati/aziende/tecnologia/591402.html susan hill susan hill The global  artificial pancreas device system  is anticipated to reach USD 390.4 million by 2024, according to a new report by Grand View Research, Inc. Increasing prevalence of diabetes, intensive R&D efforts by industry players . 

Regulatory bodies such as FDA are continuously approved. For instance, in December 2016, OneTouch Vibe plus Insulin Pump by Animas received FDA approval and Health Canada License for the sale of the product. In January 2016, Animas received FDA approval for Animas Vibe Insulin Pump, the device to manage diabetes in children and adolescents.

Similarly, in June 2016, the FDA approved Tandem Diabetes Care approval for remote software update tool for insulin pump. Also, in September 2016, the company received FDA approval for their product: slim G4 Insulin

In addition, the prevalence of diabetes is increasing in low and middle-income counties. Owing to the sedentary lifestyle, genetic modification, obesity, lack of physical activity, and unhealthy diet. According to the data published by the International Diabetes Federation (IDF), in 2015 there were about 415 million people suffering from diabetes globally. Also, based on the information provided by the American Diabetes Association, in 2012, about 29.1 million Americans suffered from type 1 and 1.25 million suffered from type 1 diabetes. In addition, the increasing dependency of type 2

Further Key Findings from the Study Suggest :

  • Control to Target (CTT) systems is anticipated to witness faster growth during the forecast period.
  • Asia Pacific artificial pancreas device
  • Major players in the market include, Medtronic Plc, Bigfoot Biomedical, Johnson & Johnson, Tandem Diabetes Care, Inc., Pancreum, Inc., TypeZero Technologies, LLC, and Beta Bionics.

Grand View Research has segmented the global artificial pancreas device system on the basis of the device type and region:

Artificial Pancreas Device System Device Type Outlook (Revenue, USD Million, 2013 - 2024)

  • Threshold suspended device system
  • CTR System
  • CTT System

Artificial Pancreas Device System Regional Outlook (Revenue, USD Million, 2013 - 2024)

  • North America
    • US
    • Canada
  • europe
    • germany
    • UK
  • Asia Pacific
    • japan
    • china
  • Latin America
    • brazil
    • mexico
  • Middle East and Africa (MEA)
    • South Africa

Access full research on global artificial pancreas device system market:  

https://www.grandviewresearch.com/industry-analysis/artificial-pancreas-device-market

]]>
Global Enteral Feeding Devices Market Size, Share, Growth, Trends and Industry Analysis Report, 2019 to 2025 Thu, 22 Aug 2019 11:06:46 +0200 http://content.comunicati.net/comunicati/aziende/tecnologia/591356.html http://content.comunicati.net/comunicati/aziende/tecnologia/591356.html susan hill susan hill The global enteral feeding devices market size is expected to reach USD 3.58 billion by 2025, at a CAGR 5.8% over a forecast period, according to a new report by Grand View Research, Inc. It is majorly driven by rising incidence of malnutrition and pre mature birth cases, prevalence of chronic disorders such as gastrointestinal disorders, cancer and neurological disorders.

Furthermore, the shift from parenteral nutrition to enteral feeding is one of the factors gaining a significant traction in the market. This is owing to the increased risk of infections due to needle stick injuries during parenteral nutrition, whereas enteral nutrition is administered directly in the gastrointestinal tract. Moreover, older patients diagnosed with chronic diseases such as cancer, inherited metabolic disease and neurological disorders are recommended with enteral nutrition. Thus, rise in the number of admissions in hospitals due to increase in the number of patients diagnosed with chronic diseases are in turn driving the demand for enteral feeding, fostering the market growth.

In 2018, World Health Organization (WHO) stated that around 15 million preterm babies are born each year and this number is constantly rising and approximately 1 million children die each year due to preterm birth complications. Furthermore, over 60% of preterm births occur in Africa and South Asia due to increasing maternal age and underlying maternal health problems such as diabetes and high blood pressure. However, one of the major concerns with premature infants is swallowing and intake of proper nutrients. Therefore, demand for enteral feeding devices has gained a significant traction to provide adequate amount of food to for the growth and development of these infants.

Further key findings from the report suggest:

  • In 2018, enteral feeding pump held the largest revenue share and is also expected to be the fastest growing segment over the forecast period, owing to the adoption of the device among patients who lacks key micronutrients
  • Nasogastric tubes held the second largest revenue share owing to the adoption of these tubes for providing medicinal and nutritional support to the ill patients
  • Introduction of low profile gastronomy devices or balloons has changed the way enteral feeding is performed. It has made the feeding and carrying the tube easy and incident free. These factors are expected to boost the adoption of low profile gastronomy tubes
  • North America held the largest revenue share of the enteral feeding devices market owing to the rising number of pre term births
  • Asia pacific expected to emerge at the fastest CAGR over the forecast period owing to the growing geriatric population and prevalence of malnutrition
  • Key players include CONMED Corporation; Abbott Nutrition; Kimberly Clark; Amsino International Inc.; Boston Scientific Corporation; Cook Medical; Moog Inc.; and Danone Medical Nutrition.

Grand View Research has segmented the global enteral feeding devices market on the basis of products and region:

Product Outlook (Revenue, USD Million, 2014 - 2025)

  • Giving set
  • Enteral feeding pump
  • Percutaneous endoscopic gastrostomy device
  • Low profile gastrostomy device
  • Nasogastric tube
  • Gastrostomy tube

Regional Outlook (Revenue, USD Million, 2014 - 2025)

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Russia
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Singapore
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Access full research report on global enteral feeding devices market: 

https://www.grandviewresearch.com/industry-analysis/enteral-feeding-devices-industry

]]>
Global Orthopedic Implants Market Size, Share, Growth, Trends and Industry Analysis Report, 2024 Wed, 21 Aug 2019 14:33:52 +0200 http://content.comunicati.net/comunicati/aziende/tecnologia/591148.html http://content.comunicati.net/comunicati/aziende/tecnologia/591148.html susan hill susan hill The global orthopedic implants market is expected to reach USD 6.2 billion by 2024, according to a new report by Grand View Research, Inc.  Major drivers, such as the surging geriatric population count and the increasing number of sports injuries are fueling the demand for the orthopedic prostheses globally.

The soaring number of road accidents and sports injuries is continually engendering the multitude of worldwide trauma cases. In addition, people above the age of 65 years are highly prone to orthopedic diseases and fractures since bone density progressively reduces with increasing age. Thus, the growth in the number of trauma cases and the escalating elderly population is further driving the target patient base for prosthetic implants.

On the other hand, the cost prohibitive nature of these implants coupled with the inadequate reimbursement coverage is the prime factor restraining the growth of the global market. In addition, the existent stringent regulatory framework and the frequent product recalls are some of the other factors further challenging the growth.

Further key findings from the study suggest:

  • The knee replacement segment captured the largest share of the global market in 2015, which is attributable mainly to the high prevalence of osteoporosis and arthritis.
  • The orthopedic implants for long bones are anticipated to show the fastest growth rate owing to the constantly rising sports injuries and accident trauma cases.
  • North America captured the largest market share of 53.4% in 2015 and is expected to maintain its dominance throughout the forecast period. The presence of a well-defined regulatory framework, recommendations of government and healthcare agencies, and the current high adoption rate of minimally invasive procedures are the major factors supporting the growth of the market in North America.
  • Asia Pacific is anticipated to exhibit fast paced growth during the forecast period due mainly to the rising disposable income, growing awareness with regard to improved and advanced orthopedic prostheses, progressively improving healthcare infrastructure, and the flourishing medical tourism industry are some of the factors rendering the Asia Pacific region attractive to the international players.
  • The global orthopedic implants market is fragmented with the presence of many local players. Thus, market players are adopting strategies including mergers and acquisitions and distribution partnerships to expand their overall market share and sustain themselves in the competition.
  • Some key players operating in this market include Zimmer Biomet Holdings, Inc., Stryker Corporation, DepuySynthes, Smith & Nephew plc, Wright Medical Group N.V, and Medtronic Plc.

Grand View Research has segmented theorthopedic implants market on the basis of application and geography:

Orthopedic Implants Market by Application, 2014 - 2024 (USD Million)

  • Spinal Fusion
  • Joint Replacement
  • Long Bones
  • Craniomaxillofacial
  • Foot & Ankle
  • Dental

Orthopedic Implants Market by Region, 2014 - 2024 (USD Million)

  • North America
    • U.S. Orthopedic Implants Market, by Application
    • Canada Orthopedic Implants Market, by Application
  • Europe
    • UK Orthopedic Implants Market, by Application
    • Germany Orthopedic Implants Market, by Application
  • Asia Pacific
    • China Orthopedic Implants Market, by Application
    • Japan Orthopedic Implants Market, by Application
  • Latin America
    • Brazil Orthopedic Implants Market, by Application
    • Mexico Orthopedic Implants Market, by Application
  • MEA
    • South Africa Orthopedic Implants Market, by Application

Access full research report on global orthopedic implants market: 

http://www.grandviewresearch.com/industry-analysis/orthopedic-implants-market

]]>
Global Neuroprosthetics Market Size, Share, Growth and Trend Analysis Report, 2024 Wed, 21 Aug 2019 14:00:20 +0200 http://content.comunicati.net/comunicati/aziende/tecnologia/591124.html http://content.comunicati.net/comunicati/aziende/tecnologia/591124.html susan hill susan hill  

The global neuroprosthetics market is expected to reach USD 14.6 billion by 2024, according to a new report by Grand View Research, Inc. The increasing prevalence of neurological disorders coupled with the demand for cost-effective and technologically advanced implants is expected to drive the demand for neuroprosthetics market in the coming years. 

In addition, the associated high costs and side effects of conventional medications are responsible for the rising adoption rate of implants. For instance, the increasing adoption of Vagus Nerve Stimulation (VNS) therapy system over therapeutics such as antidepressants in the treatment of Alzheimer's disease, brain aneurysm, and strokes is propelling the overall market growth. 

Moreover, the rising geriatric population prone to epilepsy opting for neural implantation over the conventional medication is exerting a positive effect on the overall industry growth.

Further key findings from the study suggest: 

  • The motor prosthetic devices segment dominated in terms of revenue share and accounted for over 35.0% of the market in 2015, followed by visual cochlear implants. Whereas, retinal neuroprosthetics were identified as one of the fastest growing market segment owing to the rising penetration and the increasing R&D efforts pertaining to product innovation.
  • The Spinal Cord Stimulation (SCS) segment held the largest share at over 55.0% owing to the analgesic property of the SCS therapy used in the treatment of ischemic pain, failed back surgery syndrome, and complex refractory pain syndrome. Furthermore, it finds applications in intraspinal and epidural microstimulation for inducing leg movements. In addition, technological advancements in this segment is expected to further boost market growth in the near future. The sacral Nerve Stimulation (SNS) is expected to be the fastest growing segment over the forecast period due to its applications in chronic intractable pelvic ache and neurogenic bladder.
  • In the applications segment, motor neuron disorders held the largest segment due to the rising incidences of Parkinson’s disease and epilepsy. For instance, as per the report published by Parkinson’s disease Foundation in 2012, approximately 60,000 Americans were diagnosed with Parkinson’s disease each year and the number is expected to grow further over the forecast period thereby fueling this segment’s growth.
  • In 2015, North America dominated the overall neuroprosthetics market at over 43.0% owing to the large presence of neural implants manufacturers, higher R&D investments, and the availability of funds from both government and private institutes. For instance, the Defense Advanced Research Project Agency (DARPA) and National Institute of Neurological Disorders and Stroke (NIH) in collaboration with the federal agencies are instrumental in providing funds to support R&D initiatives for the further development of neural implants.
  • Asia Pacific is anticipated to be the fastest growing segment due to the introduction of multinational healthcare establishments promoting safe and effective medical procedures along with the rising awareness levels amongst consumers
  • Strategic collaborations and mergers & acquisitions are expected to keep the industry rivalry level high over the forecast period

Grand View Research has segmented the neuroprosthetics market on the basis of type, technology, application, and region.

Global Neuroprosthetics Type Outlook (Revenue, USD Million, 2013 - 2024) 

  • Motor Prosthetics
  • Auditory Prosthetics/Cochlear Implants
  • Cognitive Prosthetics
  • Visual Prosthetics/Retinal Implants

Global Neuroprosthetics Technology Outlook (Revenue, USD Million, 2013 - 2024)

  • Deep Brain Stimulation (DBS)
  • Vagus Nerve Stimulation (VNS)
  • Spinal Cord Stimulation (SCS)
  • Sacral Nerve Stimulation (SNS)

Global Neuroprosthetics Application Outlook (Revenue, USD Million, 2013 - 2024)

  • Motor Neuron Disorders
    • Parkinson’s Disease
    • Epilepsy
  • Physiological Disorders
    • Auditory Processing Disorders
    • Ophthalmic Disorders
    • Cardiovascular Disorders
    • Kidney Diseases
  • Cognitive Disorders
    • Alzheimer’s Disease
    • Severe Depression

Neuroprosthetics Regional Outlook (Revenue, USD Million, 2013 - 2024)

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Mexico
    • Brazil
  • MEA
    • South Africa

Access full research report on global neuroprosthetics market: 

http://www.grandviewresearch.com/industry-analysis/neuroprosthetics-market

 

]]>
Global Peripheral Vascular Devices Market Size, Share, Growth, Trends and Forecast Report, 2020 Wed, 21 Aug 2019 13:19:32 +0200 http://content.comunicati.net/comunicati/aziende/tecnologia/591100.html http://content.comunicati.net/comunicati/aziende/tecnologia/591100.html susan hill susan hill The global peripheral vascular devices market is expected to reach USD 8,918.8 million by 2020, growing at an estimated CAGR of 7.2% from 2014 to 2020, according to a new study by Grand View Research, Inc. Peripheral vascular devices such as IVC filters, angiography catheters and plague modification devices are used for treating peripheral arterial or coronary arterial diseases caused due to the formation of atherosclerotic plaques in arteries. These devices are used to decrease the interference of patients with minimum disturbance during the surgical procedure.

Increasing global geriatric population base triggering incidence rates of target diseases, extensive presence of both private and public external funding programs, changing lifestyle and eating habits are expected to be key driving factors for this market over the next six years. In addition, presence of untapped growth opportunities in emerging markets such as India, Brazil and China and increasing health awareness are also expected to serve this market as future growth opportunities.

Further key findings from the study suggest:

  • Peripheral vascular stents dominated the peripheral vascular devices market in terms of share at over 30.8% in 2013; driven by increasing demand for drug eluting and bio-absorbable stents. Moreover, the ability of these devices to significantly reduce re-stenosis rates is expected to boost product demand.
  • Embolic protection devices market is expected to grow at the fastest CAGR of 9.2% during the forecast period; owing to increasing demand for minimally invasive endovascular surgical method for removing atherosclerosis from large blood vessels.
  • North America was the largest regional market in 2013, accounting for 40.3% of the global revenue. Presence of sophisticated healthcare infrastructure, high patient awareness levels, healthcare expenditure and high R&D pertaining to drug discovery and development are some of the factors accounting for its large share.
  • Asia Pacific peripheral vascular devices market is expected to grow at the fastest CAGR of 10.0% from 2014 to 2020; primarily owing to the wide presence of unmet medical needs coupled with rapidly improving healthcare infrastructure in emerging markets of India and China.
  • Key industry participants of this market include Abbott Laboratories, Angioscore Inc., Edward Lifesciences Corporation, Medtronic Inc., St. Jude Medical, Teleflex Medical, Volcano Corporation, Boston Scientific Corporation, Teleflex Medical, Cook Group Inc., Cordis Corporation, Covidien, W.L.Gore and Associates Ltd. and Angioscore Ltd.

Grand View Research has segmented the peripheral vascular devices market on the basis of product and region:

Peripheral Vascular Devices Product Outlook

  • Peripheral Vascular Stents
  • Peripheral Transluminal Angioplasty Balloon Catheters
  • PTA Guidewires
  • Atherectomy Devices
  • Chronic Total Occlusion Devices
  • Aortic Stents
  • Synthetic Surgical Grafts
  • Embolic Protection Devices
  • Inferior Vena Cava Filters

Peripheral Vascular Devices Regional Outlook

  • North America
  • Europe
  • Asia Pacific
  • RoW

Access full research report on global peripheral vascular devices market: 

http://www.grandviewresearch.com/industry-analysis/peripheral-vascular-devices-market

]]>
Phenylketonuria Treatment Market Size, Share, Growth, Trends and Industry Analysis Report, 2018 to 2025 Wed, 21 Aug 2019 12:07:04 +0200 http://content.comunicati.net/comunicati/aziende/tecnologia/591035.html http://content.comunicati.net/comunicati/aziende/tecnologia/591035.html susan hill susan hill The global phenylketonuria treatment market size is expected to reach USD 1.02 billion by 2026 registering a CAGR of 11.0%, according to a new report by Grand View Research, Inc. Rising prevalence of PKU across the world and favorable government regulations are the factors expected to spur the market growth over the forecast period.

For instance, according to the FDA, in 2018, phenylketonuria affected about 1 in 10,000 to 15,000 people in U.S. Furthermore, according to the Orphanet, it was estimated that 1 in 10,000 newborns in Europe is suffering from PKU. The target disease is highly prevalent in European countries, such as Italy, Ireland, and Turkey. It was estimated that around 1 in 4000 individuals in Turkey were diagnosed with PKU.

Various awareness programs conducted by private and public organizations are also projected to fuel market growth. Some of the organizations conducting such programs are SickKids, Children’s Hospital of Wisconsin, CHOC Children’s, and Boston Children’s Hospital. These programs aim to promote optimal emotional, developmental, and physical health PKU patients.

Furthermore, continuous R&D for the disease treatment is estimated to enhance the market growth. For instance, Synlogic, Inc.’s SYNB1618 drug is undergoing Phase 1/2a clinical trials and also received fast-track designation from FDA. In addition, other companies, such as Rubius Therapeutics, Inc., Retrophin, Inc., and Homology Medicines, Inc. are also conducting research to develop novel therapies, such as oral, enzyme therapy, gene therapy.

Availability of reimbursement policies for high-cost treatments of PKU is also projected to boost the market growth. Kuvan is currently approved for use and reimbursed in many European countries, such as Germany, Belgium, France, Italy, and Austria. Furthermore, increasing number of funding programs for R&D by various organizations is anticipated to drive the market. For instance, the National PKU Alliance provides funding to research projects that helps in promoting advances in the management and treatment of PKU.

Further key findings from the study suggest:

  • Kuvan held the largest market share in 2018 as it is the first and only approved drug for PKU treatment since 2007
  • North America dominated the phenylketonuria treatment market in 2018 owing to the presence of well-established healthcare infrastructure, high healthcare expenditure, and favorable government regulations
  • Europe region is expected to exhibit the fastest CAGR over the forecast period owing to rising R&D activities for the development of new PKU drugs
  • Major companies in the market are BioMarin Pharmaceuticals, Inc.; Retrophin, Inc.; Synlogic, Inc.; Censa Phamraceuticals; Homology Medicinces, Inc.; and Rubius Therapeutics, Inc.

Grand View Research has segmented the global phenylketonuria treatment market on the basis of drug and region:

Phenylketonuria Treatment Drug (Revenue, USD Million, 2015 - 2026)

  • Kuvan
  • Palynziq
  • CNSA-001
  • SYNB1618

Phenylketonuria Treatment Regional Outlook (Revenue, USD Million, 2015 - 2026)

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Turkey
    • Ireland
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Brazil
    • Mexico
  • MEA
    • Saudi Arabia
    • United Arab Emirates

Access full research report on global cancer phenylketonuria treatment market: 

https://www.grandviewresearch.com/industry-analysis/phenylketonuria-pku-treatment-market

]]>
Cancer Immunotherapy Drug Discovery Outsourcing Market Size, Share, Growth and Forecast Report, 2018 to 2025 Wed, 21 Aug 2019 11:11:26 +0200 http://content.comunicati.net/comunicati/aziende/tecnologia/590979.html http://content.comunicati.net/comunicati/aziende/tecnologia/590979.html susan hill susan hill The global cancer immunotherapy drug discovery outsourcing market size is projected to reach USD 1.7Billion by 2025, according to a new report by Grand View Research, Inc., rising at a CAGR of 13.5% during the forecast period. Increasing prevalence of cancer and rising mortality associated with cancer, along with growing development in the field of cancer immunotherapy, are anticipated to stimulate the growth of the market.

In order to maintain pace with increasing competition in the cancer therapeutics industry, pharmaceutical companies spend 2.5% more than other high tech industries in the in-house R&D. Hence, they are swiftly shifting towards outsourcing of drug discovery in order to achieve lower in-house R&D costs.

Additionally, favorable tax credit allows pharmaceutical companies to appropriately plan their global projects with a reputed CRO and therefore, receive benefits and reduce problems associated with taxation authorities or other bodies administering such incentive programs.

Several new molecules for cancer immunotherapy and new immunotherapeutic options, such as tumor infiltrating lymphocytes, check point inhibitors immunomodulators, and CAR-T cell therapy, have been introduced. Some are in the pipeline and are being tested for their ability to provide better cancer treatment

Further Key Findings from the Report Suggest:

  • Monoclonal antibodies emerged as the largest segment in 2017 because of increasing regulatory approvals and higher efficacy
  • Target identification and validation accounted for the largest share in the global market owing to higher costs incurred and increased investments in new drug development
  • North America dominated the market with the largest share in 2017. Rising incidence of cancer and increasing demand for novel technologies are facilitating the dominance of the region during the forecast period
  • Some of the key players are Covance, Inc.; Explicyte; Aquila BioMedical; Horizon Discovery Group PLC; Crown Bioscience, Inc.; Promega Corporation; HD Biosciences Co., Ltd.; BPS Bioscience, Inc.; Genscript Biotech Corporation; DiscoverX Corporation; Celentyx Ltd.; ImmunXperts SA; Personalis, Inc.; STC Biologics; and Molecular Imaging, Inc. dominated the cancer immunotherapy drug discovery outsourcing market.

Grand View Research has segmented the global cancer immunotherapy drug discovery outsourcing market based on drug type, service type, cancer type, and region:

Cancer Immunotherapy Drug Discovery Outsourcing Drug Type Outlook (Revenue, USD Million, 2014 - 2025)

  • Monoclonal Antibodies
  • Immunomodulators
  • Oncolytic Viral Therapies and Cancer Vaccines

Cancer Immunotherapy Drug Discovery Outsourcing Service Type Outlook (Revenue, USD Million, 2014 - 2025)

  • Target Identification and Validation
  • Lead Screening and Characterization
  • Cell Based Assays

Cancer Immunotherapy Drug Discovery Outsourcing Cancer Type Outlook (Revenue, USD Million, 2014 - 2025)

  • Lung Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Melanoma
  • Prostate Cancer
  • Head and Neck Cancer
  • Ovarian Cancer
  • Pancreatic Cancer

Cancer Immunotherapy Drug Discovery Outsourcing Regional Outlook (Revenue, USD Million, 2014 - 2025)

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
  • Asia Pacific
    • India
    • China
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • South Africa

Access full research report on global cancer immunotherapy drug discovery outsourcing market: 

https://www.grandviewresearch.com/industry-analysis/cancer-immunotherapy-drug-discovery-outsourcing-market

]]>
Assisted Reproductive Technology Market Size, Share, Growth and Trend Analysis Report, 2018 to 2025 Wed, 21 Aug 2019 10:54:05 +0200 http://content.comunicati.net/comunicati/aziende/tecnologia/590971.html http://content.comunicati.net/comunicati/aziende/tecnologia/590971.html susan hill susan hill The global assisted reproductive technology (ART) market is expected to reach USD 45.4 billion by 2025, according to a new report by Grand View Research, Inc. Childbearing postponement is one of the high impact rendering drivers of the infertility treatment market. The reproductive behavior and pattern of some of the nations such as few European nations have shifted from early to late childbearing pattern.

Increasing marital age, rising tobacco and alcohol consumption, increasing obesity rate are some of the other factors contributing to the market growth. Furthermore, increasing incidence rate of conditions such as poly-cystic ovarian syndrome (PCOS), tubal factors and endometriosis are other drivers of the market.

According to the Society for Assisted Reproductive Technology, 2012 was the year with highest percentage of babies born through IVF treatment. The treatment has become more successful and has gained more acceptance, which is further expected to increase the market size in the coming years.

Further Key Findings from the Report Suggest:

  • Fresh non-donor was the largest ART market procedure segment in 2014. The fact that fresh eggs and sperms increase the number of successful pregnancies is expected to drive segment growth over the forecast period.
  • According to a recent study published in the New England Journal of Medicine by the researchers from Vietnam and China, frozen embryos are not more effective in comparison to the fresh embryos for all women, specifically those suffering from PCOS.
  • Frozen non-donor is identified as the most lucrative procedure segment of the assisted reproductive technology industry. A new study claims that the fertility treatment with frozen embryos may have more probability of success than those performed with fresh embryos.
  • IVF with ICSI dominated the technology type market segment owing to increase in the chances of successful fertilization, and exceptional technique for treating male infertility. As per the study published in fertility journal Human Reproduction Update 2017, North America, Europe, New Zealand and Australia, men’s sperm counts declined by 50-60% over the period between 1973 and 2011. Changing lifestyle and environmental factors are some of the factors responsible for the decline of sperm counts.
  • Frozen embryo replacement (FER) is anticipated to grow at a rapid rate over the forecast period owing to the fact that in the clinics fresh embryos are used first and only good quality and spare embryos are transferred at a later stage. The trend is to transfer single embryos rather than risking by transferring two or more embryos. This is expected to increase the FER segment market in the coming years.
  • Europe dominated the market and is anticipated to maintain its dominance during the forecast period The Asia Pacific region is likely to witness significant growth over the next decade due to improving healthcare infrastructure, increasing awareness and adoption of IVF procedures.
  • Technological advancements is expected to drive the market in the coming years. In 2016, INVO Bioscience, Inc. announced the FDA approval of first intravaginal culture system, INVOcell, wherein women’s vagina is used as a natural incubator and the clinical trials have produced pregnancy similar to traditional IVF treatments
  • Some of the key players are California Cryobank, Bloom IVF Centre, Parallabs, OvaScience, Anecova, Origio, Microm Ltd., Merck KGaA, Ferring Pharmaceuticals, Boston Science Corporation and Hamilton Throne Ltd.

Grand View Research has segmented the global assisted reproductive technology market based on procedure, type, end use and region:

Procedure Outlook (Revenue, USD Million, 2014 - 2025)

  • Fresh Donor
  • Fresh Non-Donor
  • Frozen Donor
  • Frozen Non-donor
  • Embryo/Egg Banking

Type Outlook (Revenue, USD Million, 2014 - 2025)

  • In-Vitro Fertilization (IVF)
    • IVF with Intracytoplasmic Sperm Injection (ICSI)
    • IVF without Intracytoplasmic Sperm Injection (ICSI)
  • AI-IUI (Artificial Insemination - Intrauterine Insemination
  • Frozen Embryo Replacement (FER)
  • Others

End Use Outlook (Revenue, USD Million, 2014 - 2025)

  • Hospitals
  • Fertility Clinics

Regional Outlook (Revenue, USD Million, 2014 - 2025)

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • South Africa

Access full research report on global assisted reproductive technology (ART) market: 

https://www.grandviewresearch.com/industry-analysis/assisted-reproductive-technology-market

]]>
Rat Model Market Size, Share, Growth and Trend Analysis Report, 2018 to 2025 Tue, 20 Aug 2019 16:09:53 +0200 http://content.comunicati.net/comunicati/aziende/tecnologia/590823.html http://content.comunicati.net/comunicati/aziende/tecnologia/590823.html susan hill susan hill The global rat model market is expected to reach USD 845.0 million by 2025, according to a new report by Grand View Research, Inc. As of 2016, outbred type of rat model is commonly utilized for research and educational activities within the healthcare domain. However, advancement in production technologies is expected to boost growth of knockout and conditioned rats.

The production technologies for aforementioned type of model are recent in nature and can be traced back to 2008, post the development of mobile DNA technology. The first knockout model was introduced in 2009 using Zinc Finger Nuclease (ZFN) method, which led to an advancement in the field of rat models. Other tools for genetic editing are Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), homologous recombination, and N-ethyl-N-nitrosourea (ENU) mutagenesis.

Furthermore, supportive infrastructure and technology coupled with growing incidence of chronic conditions & genetic mutation amongst human species are expected to extend higher applicability for research purposes, thereby boosting growth.

Further key findings from the study suggest:

  • Outbred is expected to dominate the type segment for rat model market. Presence of numerous outbred type and higher applicability of these to mimic human diseases is anticipated to support growth over the forecast period.
  • Microinjection is anticipated to witness the fastest growth over the forecast period owing to faster development of the models and reduction in breeding time. Similarly, development of newer technology within the other segment is expected to propel growth.
  • Based on services, the rat model market is predicted to witness higher revenue contribution by breeding process. Cryopreservation is anticipated to witness fastest growth over the forecast period.
  • Rising production of conditioned rats for behavioral studies and growing R&D within neurological application is expected to support lucrative growth of rat model. Other application expected to support growth include cardiovascular disorders, diabetes, obesity, and renal disorders.
  • The key market players of the industry include Covance Inc.; Envigo; Charles River Laboratories International, Inc.; Horizon Discovery Group plc.; TransViragen, Inc.; Javier Labs; and others. Mergers & acquisitions are expected to strengthen company capabilities. For instance, Horizon Discovery Group plc. accomplished the aforementioned goal by acquiring SAGE Labs, Inc. in 2014.

Grand View Research has segmented the global rat model market on the basis of type, technology, service, application, end-use, and region:

Global Rat Model Type Outlook (Revenue, USD Million, 2014 - 2025)

  • Knockout
  • Outbred
  • In bred
  • Hybrid
  • Immunodeficient
  • Conditioned

Global Rat Model Technology Outlook (Revenue, USD Million, 2014 - 2025)

  • Nuclear transferase
  • Microinjection
  • Embryonic stem cell
  • Other

Global Rat Model Service Outlook (Revenue, USD Million, 2014 - 2025)

  • Cryopreservation
  • Breeding
  • Re-derivation
  • Genetic testing
  • Quarantine
  • Other

Global Rat Model Application Outlook (Revenue, USD Million, 2014 - 2025)

  • Oncology
  • Neurology
  • Immunology
  • Toxicology
  • Other

Global Rat Model End-use Outlook (Revenue, USD Million, 2014 - 2025)

  • CROs
  • Academic and research institutes
  • Healthcare companies

Rat Model Regional Outlook (Revenue, USD Million, 2014 - 2025)

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • Japan
    • China
  • Latin America
    • Brazil
    • Mexico
  • Middle East and Africa (MEA)
    • South Africa

Access full research report on global rat model market: 

http://www.grandviewresearch.com/industry-analysis/rat-model-market

]]>
Global Botulinum Toxin Market Size, Share, Growth, Trends and Industry Statistics Report, 2018 to 2025 Tue, 20 Aug 2019 15:28:10 +0200 http://content.comunicati.net/comunicati/aziende/tecnologia/590809.html http://content.comunicati.net/comunicati/aziende/tecnologia/590809.html susan hill susan hill The global botulinum toxin (BNT) market is expected to reach a value of USD 7.3 billion by 2025. The constant introduction of innovative products for enhancement of aesthetic appeal supporting minimally invasive aesthetic treatments is the prime factor driving the growth of the market.

In addition, rapid growth of the sector is attributed to the rising demand for minimally invasive or non-invasive procedures. These procedures provide advantages such as small incision, shorter hospital stay and rapid wound healing, and hence lead to larger acceptance and demand. In addition, availability of wide variety of minimally invasive or non-invasive treatment options is pushing the global botulinum toxin market towards growth.

Also, the successful completion of research projects is expected to expand the applications of presently approved products. Companies are trying to widen the application of botulinum toxin in therapeutic area through various research activities. For instance, Botox by Allergan received the U.S. FDA approval for the treatment of strabismus (crossed eyes) and blepharospasm associated with dystonia in 1989. Furthermore, in 2004, Botox was approved by the U.S. FDA for hyperidrosis, cervical dystonia, upper limb spasticity, chronic migraine and urinary incontinence in 2009, 2010 and 2011 respectively. Hence, these factors all together will aid in boosting the growth of BNT sales during the forecast period.

Further Key Findings from the Study Suggest:

  • The rapid adoption of minimally invasive treatment is augmenting the growth of neurotoxins market.
  • The botulinum toxin type A segment accounted for the largest share in 2015 and is also anticipated to be the fastest growing segment during the forecast period
  • In 2015, North America dominated the global space with the largest revenue share owing to high demand for minimally invasive or non-invasive aesthetic treatments
  • Asia Pacific is expected to emerge as the fastest growing region during the forecast period, mainly due to growing social awareness regarding anti-wrinkle procedures in India, China, and Japan
  • Major players competing in this market include but are not limited to Allergan, Inc.; Ipsen Group; Merz GmbH and Co. KGaA, Medytox,Inc.; US Worldmed, LLC; Lanzhou Institute of Biological Products. Co.Ltd. and Revance Therapeutics, Inc.

Grand View Research has segmented the botulinum toxin market by type, end use, and region:

Product Type Outlook (Revenue, USD Million; 2013 - 2025)

  • Botulinum Toxin Type A
  • Botulinum Toxin Type B

End Use Outlook (Revenue, USD Million; 2013 - 2025)

  • Therapeutic
  • Aesthetic

Regional Outlook (Revenue, USD Million; 2013 - 2025)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • China
    • Japan
  • Latin America
    • Mexico
    • Brazil
  • MEA
    • South Africa

Access full research report on global botulinum toxin market: 

http://www.grandviewresearch.com/industry-analysis/botulinum-toxin-market

]]>
Global Blood Preparation Market Size, Share, Growth, Trends and Industry Analysis Report, 2019 to 2026 Tue, 20 Aug 2019 14:46:50 +0200 http://content.comunicati.net/comunicati/aziende/tecnologia/590793.html http://content.comunicati.net/comunicati/aziende/tecnologia/590793.html susan hill susan hill The global blood preparation market size is expected to reach USD 56.78 billion by 2026 registering a CAGR of 5.6%, according to a new report by Grand View Research, Inc. Demand for transfusion of blood and its components and increasing prevalence of blood-related disorders are expected to fuel the growth of this market over the forecast period.

Increasing prevalence of thrombocytosis-associated disorders is also likely to boost market growth. According to the Centers for Disease Control and Prevention (CDC), around 900,000 individuals are affected by Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) in U.S. each year, and 60,000-100,000 Americans die due to DVT/PE. Commercialization of drugs currently in the pipeline and introduction of new oral anticoagulants are expected to drive the market further.

Anticoagulants was the largest product segment in 2018 owing to increased R&D aimed at the development of novel prophylactic and therapeutic drugs. Re-launch of some key drug products, such as Urokinase in North America, are also likely to propel market growth over the coming years.

The market in Asia Pacific is also anticipated to witness high growth in future, owing to the presence of favorable government initiatives, sophisticated healthcare infrastructure, especially in Japan and Australia, and several untapped opportunities in the emerging markets of China and India.

Further key findings from the study suggest:

  • Whole blood product segment held the largest share in 2018 due increased number of surgeries and trauma cases
  • Blood derivatives is estimated to be the fastest-growing segment due to use of these products in patients affected with infectious diseases, such as Ebola
  • Anticoagulants dominated the antithrombotic and anticoagulants product segment and are likely to witness the fastest CAGR of 5.8% due to launch of novel and efficient anticoagulant drugs in market
  • The direct factor Xa inhibitors is the most lucrative segment on account of the introduction of new oral products, such as Xarelto, aimed at addressing unmet medical needs
  • Angina blood vessel complications was the largest application segment due to rise in lifestyle-associated diseases and popularity of oral anticoagulants
  • North America was the largest regional blood preparation market in 2018 and will maintain the dominance over the forecast years
  • Presence of sophisticated healthcare infrastructure along with high patient awareness and healthcare expenditure levels in North America will drive the regional market
  • Key companies in the market include GlaxoSmithKline PLC; Pfizer, Inc.; Baxter International, Inc.; Bristol-Myers Squibb Company; LEO Pharma A/S; Sanofi S.A.; Portola Pharmaceuticals, Inc.; and AstraZeneca PLC

Grand View Research has segmented the global blood preparation market on the basis of product, type, application, and region:

Blood Preparation Product Outlook (Revenue, USD Million, 2014 - 2026)

  • Whole Blood
    • Red Cells
    • Granulocytes
    • Plasma
    • Platelets
  • Blood Components
    • Whole Blood Components
    • Packed Red Cells
    • Leukocyte Reduced Red Blood Cells
    • Frozen Plasma
    • Platelet Concentrate
    • Cryoprecipitate
  • Blood Derivatives

Antithrombotic and Anticoagulants Type Outlook (Revenue, USD Million, 2014 - 2026)

  • Platelet Aggregation Inhibitors
    • Glycoprotein Inhibitors
    • COX Inhibitors
    • ADP Antagonists
    • Others
  • Fibrinolytics
    • Tissue Plasminogen Activator (tPA)
    • Streptokinase
    • Urokinase
  • Anticoagulants
    • Heparins
  •  
    •  
      • Unfractionated Heparin
      • Low Molecular Weight Heparin (LMWH)
      • Ultra-low Molecular Weight Heparin
    • Vitamin K Antagonists
    • Direct Thrombin Inhibitors
    • Direct Factor Xa Inhibitors

Antithrombotic and Anticoagulants Application Outlook (Revenue, USD Million, 2014 - 2026)

  • Thrombocytosis
  • Pulmonary Embolism
  • Renal Impairment
  • Angina Blood Vessel Complications
  • Others

Blood Preparation Regional Outlook (Revenue, USD Million, 2014 - 2026)

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Spain
    • France
    • Italy
    • Russia
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Singapore
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Access full research report on global blood preparation market: 

https://www.grandviewresearch.com/industry-analysis/blood-preparation-market

]]>
Enteric Disease Testing Market Size, Share, Growth, Trends and Forecast Report, 2018 to 2025 Tue, 20 Aug 2019 14:19:22 +0200 http://content.comunicati.net/comunicati/aziende/tecnologia/590779.html http://content.comunicati.net/comunicati/aziende/tecnologia/590779.html susan hill susan hill The global enteric disease testing market is expected to reach USD 4.2 billion by 2025 according to a new study by Grand View Research Inc. Increasing demand for rapid diagnosis in order to treat diseases such as cholera, and other diarrheal diseases, rise in the aging population accompanied with unhygienic living conditions and growing application of medical testing for enteric diseases are expected to drive the market over the forecast period.

The growth is further attributed to rising healthcare expenditure, supportive government initiatives, and augmenting disease prevalence rate. Economic and environmental factors such as poor sanitation and rising population living below the poverty line with no access to hygienic food and water supply are attributed to growing incidence rate of the infections and thus propel the market growth.

According to database of Bill and Melinda Gate Foundation, enteric diseases were responsible for about 500,000 deaths each year and these are anticipated to increase further. The highest mortality rate was observed amongst people above 75 years of age followed by children under 5 year of age.

Strategic initiatives by healthcare federal bodies such as the WHO and UNICEF, to manage the disease fatality effectively are expected to assist market growth. These agencies are working towards promoting widespread testing of people for such infections by conducting awareness programs and healthcare camps. They also fund local agencies in third world countries to limit the spread of these infections.

Further key findings from the study suggest:

  • Bacterial enteric disease testing market is expected to dominate the market in 2025 with revenue share of over 60.32% in 2016 due to higher occurrence of these infections. According to research conducted by Johns Hopkins Bloomberg School of Public Health, around four to six million people die annually due to bacterial infection induced diarrhea.
  • Parasitic enteric disease testing market is expected to register significant growth with CAGR of 1.9%. The WHO has estimated over 200 million people to be infected annually by parasites such as giardia lamblia, cryptosporidium and E. histolytica.
  • North American region is anticipated to contribute for 26.55% revenue in 2025, owing to rising geriatric population base, increasing number of immigrants, and rising patient awareness levels coupled with relatively higher healthcare expenditures in the region.
  • Asia Pacific region is projected to reach over USD 1.0 billion by registering lucrative growth rate in 2025. Government efforts in countries such as Japan, China, and India to increase awareness and promote higher testing are expected to drive the market over the forecast period.
  • Major market players are Alere Inc., Quest Diagnostics, Becton Dickinson & Company, bioMerieux, Bio-Rad Laboratories and Cepheid.
  • Industry players are constantly fueling the market with new product launches or upgrading the existing technology. In January 2015, Biomerica filed a patent application with the U.S. Patent and Trademark Office for a test used in detection of gastrointestinal disorder.
  • Apart from technology innovation, many industry players are collaborating to use each other’s strength and are formulating strategic alliances in order to incur higher profits. For instance, in May 2017, Quest diagnostics announced collaboration with PeaceHealth to enhance the service through high value design and innovation.

Grand View Research has segmented the global enteric disease testing market on the basis of disease type and region:

Global enteric disease testing disease type outlook (Revenue, USD Million, 2014 - 2025)

  • Bacterial enteric diseases
  • Viral enteric diseases
  • Parasitic enteric diseases

Global enteric disease testing regional outlook (Revenue, USD Million, 2014 - 2025)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • MEA

Access full research report on global enteric disease testing market: 

http://www.grandviewresearch.com/industry-analysis/enteric-disease-testing-market

]]>
Medical Document Management Systems Market Size, Share, Growth and Trend Analysis Report, 2018 to 2025 Tue, 20 Aug 2019 12:18:08 +0200 http://content.comunicati.net/comunicati/aziende/tecnologia/590652.html http://content.comunicati.net/comunicati/aziende/tecnologia/590652.html susan hill susan hill The global medical document management systems market size is expected to reach USD 0.63 billion by 2025, according to a new report by Grand View Research, Inc. The global market is estimated to register a CAGR of 10.2% during the forecast period. The sector has experienced noticeable growth in the past few years owing to rising burden of paper management and storage.

Medical document management solutions such as hospital information systems, patient monitoring system, Electronic Medical Record (EMR), and e-prescribing methods facilitate managing medical records like insurance cards/claims, admission forms, invoices, and records of laboratory results. Rising need for ease of managing large amounts of healthcare data along with increasing demand for Electronic Health Record (EHR) and Clinical Trial Management System (CTMS) is expected to propel market demand.

Various government initiatives to develop healthcare IT and clinical document managing software sector globally are the key drivers of the market. For instance, the 58th World Health Assembly; where the WHO urged member states to promote EHR and health documentation and create awareness regarding the same. Apart from this, there are many region-specific initiatives that are promoting the adoption of these services. For instance, the Health Department Republic of South Africa set guidelines for healthcare IT strategy in the region.

Further key findings from the study suggest:

  • Need for creating paperless environment while reducing manual errors is expected to drive market growth
  • Cloud-based system is anticipated to be the fastest-growing segment over the forecast period owing to low cost of installation, implementation, and set up of these systems
  • Hospitals and clinics led the end-user segment with the highest revenue share. Increasing number of hospital admissions is driving the demand for medical document management systems
  • North America is the largest revenue-generating geography followed by Europe. This growth is attributed to the presence of highly-developed healthcare infrastructure and well-defined regulatory frameworks
  • Asia Pacific is expected to be the fastest-growing regional market over the forecast period. Increasing government initiatives such as implementation of e-Health, huge funding for the development of infrastructure and healthcare IT would fuel the market growth in the near future
  • Key players in the market are 3M Company; Allscripts Healthcare Solutions, Inc.; Athena Health Inc.; Cerner Corporation; Siemens AG; and GE Healthcare
  • Several other private companies in the market are EPIC Systems Corporation; NextGen Healthcare Information Systems; and Kofax Ltd.

Grand View Research has segmented the global medical document management system market on the basis of mode of delivery, product, end-user, and region:

Medical Document Management System Mode of Delivery Outlook (Revenue, USD Million, 2014 - 2025)

  • On-premises
  • Web-based
  • Cloud-based

Medical Document Management System Product Outlook (Revenue, USD Million, 2014 - 2025)

  • Solution
    • Standalone
    • Integrated
  • Services
    • Medical Planning and Management Services
    • Support Services

Medical Document Management System End-user Outlook (Revenue, USD Million, 2014 - 2025)

  • Hospital/Clinics
  • Insurance Providers
  • Nursing Homes
  • Other Healthcare Organizations

Medical Document Management System Regional Outlook (Revenue, USD Million, 2014 - 2025)

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
  • Asia Pacific
    • Japan
    • China
  • Latin America
    • Brazil
    • Mexico
  • MEA
    • South Africa

Access full research report on global medical document management systems market: 

https://www.grandviewresearch.com/industry-analysis/medical-document-management-systems-market

]]>
Coronary Artery Bypass Graft (CABG) Procedures Market Size, Share, Growth, Trends and Industry Analysis Report, 2019 to 2025 Tue, 20 Aug 2019 11:33:31 +0200 http://content.comunicati.net/comunicati/aziende/tecnologia/590615.html http://content.comunicati.net/comunicati/aziende/tecnologia/590615.html susan hill susan hill  

The global coronary artery bypass graft procedures market size is expected to reach USD 18 billion by 2025, according to a report published by Grand View Research, Inc. It is anticipated to expand at a CAGR of 1.7% over the forecast period. Rise in cardiovascular disorders coupled with growing medical tourism for cardiac procedures in the emerging countries is anticipated to fuel the growth.

In 2018, saphenous vein graft held the largest market share of 41.0% and is anticipated to expand at a significant CAGR over the forecast period. Moreover, other grafts are expected to emerge as the fastest growing segment with a CAGR of 2.0% from 2019 to 2025. The high growth is anticipated on account of the rising adoption of radial and gastroepiploic grafts for the revascularization procedures.

The triple coronary artery bypass graft (CABG) surgery segment held the largest market share of 32.3% in 2018. The increasing prevalence of cardiovascular diseases is expected to drive the demand for triple CABG surgery. Moreover, double CABG surgery segment is expected to emerge as the fastest growing segment from 2019 to 2025.

North America led the CABG procedure market in 2018, with a revenue of USD 11.54 billion and is expected to register the fastest CAGR over the forecast period. Some of the key reasons attributed to the high share include the high per capita expenditure. Moreover, favorable reimbursement policies for CABG procedures and ease of availability of grafts are anticipated to positively influence the regional growth.

Further key findings from the report suggest:

  • Saphenous vein grafts segment held the leading market share of about 41.0% in 2018, owing to an increasing number of coronary bypass procedures across the globe
  • Double CABG surgery segment is anticipated to expand at the fastest CAGR of 2.0% owing to the prevalence of various cardiovascular diseases such as coronary artery diseases, strokes, and myocardial infarction
  • North America led the CABG procedure market in 2018 with a revenue of USD 11.54 billion owing to the increasing number of CABG procedures in this region

Grand View Research has segmented the global CABG procedure market on the basis of graft type, product type, and region:

Coronary Artery Bypass Graft (CABG) Procedures Graft Type Outlook (Revenue, USD Million, 2014 - 2025)

  • Saphenous Vein Grafts
  • Internal Thoracic Artery Grafts
  • Other Grafts
    • Radial Artery
    • Gastroepiploic Artery

Coronary Artery Bypass Graft (CABG) Procedures Surgery Type Outlook (Revenue, USD Million, 2014 - 2025)

  • Single CABG Surgery
  • Double CABG Surgery
  • Triple CABG Surgery
  • Quadruple CABG Surgery

Coronary Artery Bypass Graft (CABG) Procedures Regional Outlook (Revenue, USD Million, 2014 - 2025)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • Spain
    • France
    • Italy
    • Russia
  • AsiaPacific
    • Japan
    • China
    • India
    • South Korea
    • Singapore
    • Australia
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE

Access full research report on global coronary artery bypass graft (CABG) procedures market: 

https://www.grandviewresearch.com/industry-analysis/coronary-artery-bypass-graft-procedures-market

 

]]>
Elastography Imaging Market Size, Share, Growth, Trends, Regional Outlook and Forecast, 2019 to 2026 Tue, 20 Aug 2019 11:00:30 +0200 http://content.comunicati.net/comunicati/aziende/tecnologia/590602.html http://content.comunicati.net/comunicati/aziende/tecnologia/590602.html susan hill susan hill The global elastography imaging market size is expected to reach USD 3.5 billion by the end of 2026, according to a new report by Grand View Research, Inc., registering a 7.8% CAGR over the forecast period. Increasing incidence of breast cancer and chronic liver disorders is expected to significantly drive the market. Additionally, increasing demand for minimally-invasive procedures and ongoing studies to assess the potential applications of elastography are factors expected to contribute toward rapid growth.

Currently elastography has wide applications in assessing breasts, thyroid, prostate, and liver. Increasing number of ongoing studies are expected to increase its applications in diagnosis of various conditions such neurodegenerative disorders and chronic kidney diseases. It has shown promising results for its use in assessment of kidney health during and after transplantation.

North America dominated the market in 2018 and is expected to continue its dominance during the forecast period. The elastography imaging market growth observed in the region is due to the presence of a large number of global players, along with high adoption rate for advanced imaging techniques.

Growing strategic alliances among players for development and distribution of products is expected to propel the market during the forecast period. Moreover, development of new surgical centers in different locations will increase the adoption of advanced imaging systems.


Further key findings from the report suggest
:

  • By modality, the ultrasound segment is predicted to register significant growth during the forecast period owing to advantages such as low price, accessibility, and high degree of measurement for tissue deformation
  • On the basis of end use, the hospital segment is anticipated to hold the largest share in the market during the forecast period due to rising number of ultrasound and MRI-based elastography procedures and growing trends of hospital-based imaging facilities
  • By way of application, the radiology domain is predicted to hold a large share in the market over the forecast period owing to increase in demand in image-guided radiotherapy and radiology ultrasound
  • Asia Pacific is anticipated to witness lucrative growth during the forecast period due to improving healthcare facilities and rising geriatric population who are prone to developing targeted disorders
  • Major players in the elastography imaging industry are focusing on growth strategies such as partnerships, collaborations, mergers, and acquisitions. Some of the leading players are Esaote SpA; Canon Medical Systems Corporation; Koninklijke Philips N.V.; Hitachi, Ltd.; GE Healthcare; Mindray Bio-Medical Electronics Co., Ltd.; Siemens Healthineers; Toshiba America Medical Systems, Inc.; and Samsung Medison Co., Ltd.

Grand View Research has segmented the global elastography imaging market on the basis of modality, application, end use, and region:

Elastography Imaging Modality Outlook (Revenue, USD Million, 2015 - 2026)

  • Ultrasound
  • Magnetic Resonance

Elastography Imaging Application Outlook (Revenue, USD Million, 2015 - 2026)

  • Radiology
  • Cardiology
  • Obstetrics
  • Urology
  • Vascular
  • Orthopedic and Musculoskeletal
  • Others

Elastography Imaging End-use Outlook (Revenue, USD Million, 2015 - 2026)

  • Hospitals
  • Ambulatory Surgery Centers
  • Others

Elastography Imaging Regional Outlook (Revenue, USD Million, 2015 - 2026)

  • North America

o    U.S.

o    Canada

  • Europe

o    Germany

o    U.K.

o    France

o    Italy

o    Spain

  • Asia Pacific

o    China

o    Japan

o    India

o    Thailand

o    South Korea

  • Latin America

o    Brazil

o    Mexico

o    Argentina

o    Colombia

  • Middle East & Africa

o    South Africa

o    Saudi Arabia

o    UAE

Access full research report on global elastography imaging market: 

https://www.grandviewresearch.com/industry-analysis/elastography-imaging-market

]]>
Global DNA Testing Market Size, Share, Growth, Trends and Industry Analysis Report, 2022 Mon, 19 Aug 2019 16:09:56 +0200 http://content.comunicati.net/comunicati/aziende/tecnologia/590476.html http://content.comunicati.net/comunicati/aziende/tecnologia/590476.html susan hill susan hill Global DNA testing market is anticipated to reach USD 10.04 billion by 2022, according to a new study by Grand View Research Inc. Rise in developments in the field of genome sequencing and personalized DNA level diagnostic applications, a considerable growth in the number of patented research initiatives by the government and government funded projects are factors expected to drive demand during the forecast period.

Introduction of novel technologies for genome profiling are expected to boost progress of this industry over the forecast period. Furthermore, increasing incidences of chronic oncology and infectious diseases that depend on DNA prototyping for treatment and diagnosis using personalized medicine are anticipated to significantly raise demand for DNA diagnostics/testing based research thereby propelling industrial growth in the coming years. Increasing demand for prenatal testing and in-vitro fertilization that subsequently leads to rise in demand for DNA diagnostics/testing is also attributive towards expected progress in this market.

Further key findings from the study suggest:

  • PCR based diagnosis accounted for the largest share of the market revenue in 2014 as a result of higher preference rate coupled with higher availability of products and reagent kits of this segment.
  • Next generation sequencing application for DNA testing is estimated to witness significant progress with a double digit CAGR of over 16% amongst the other technology segments due to presence of significant advantages offered by this technique of DNA identification and testing.
  • Infectious disease diagnostics accounted for the largest market share in 2014 due to higher incidence rate of various infectious disorders which subsequently raises the demand for in-vitro nucleic acid based diagnostic tests for diagnosis and monitoring of disease progression.
  • There are diverse applications of DNA testing market out of which oncology diagnostics and histopathology is estimated to register lucrative growth over the forecast period. Factors attributing for considerable growth potential in this segment include identification of cancer causing genes & associated research, and facilitation in mutation detection
  • North America dominated the market in 2014, with revenue estimated at over USD 2,600 million. Presence of sophisticated healthcare infrastructure, rising incidence of genetic abnormalities, favorable government initiatives with respect to genetic diagnosis and its application in in-vitro fertilization are major factors driving growth of this region.
  • Asia Pacific is anticipated to witness lucrative growth as a result of developments in health care infrastructure in this region coupled with presence of significant number of target population that is suffering with chronic as well as acute disorders. Government initiatives taken up herein are also attributive to influence sector growth to a great extent.
  • Key participants of DNA testing industry include Abbott Laboratories, Agilent Technologies Inc., Illumina Inc., Beckman Coulter Inc., Bio-Rad Laboratories, Thermo Fisher Scientific, Applied Biosystems Group, Cepheid Inc., Transgenomic Inc., Siemens Healthcare, Roche Diagnostics, Qiagen, Illumina, GE Healthcare, Alere Inc, Affymetrix Inc., Hologic, Dako, and 454 Life Sciences.

Grand View Research has segmented DNA testing market on the basis of technology, application, and region:

 Global DNA Diagnostics/Testing Technology Outlook (Revenue, USD Million, 2012 - 2022)

  • Microarrays based diagnostics
  • PCR based diagnostics
  • In-situ hybridization diagnostics
  • NGS DNA diagnosis

Global DNA Diagnostics/Testing Application Outlook (Revenue, USD Million, 2012 - 2022)

  • Prenatal DNA Carrier Screening
  • Preimplantation Diagnosis
  • Newborn Genetic Screening
  • Infectious Disease Diagnostics
    • HBV Diagnostic
    • HCV Diagnostic
    • HIV Diagnostic
    • TB Diagnostic
    • CT/NG Diagnostic
    • HPV Diagnostic
    • MRSA Diagnostic
    • Others
  • Oncology Diagnostics & Histopathology
  • Identity Diagnostics & Forensics
  • Pharmacogenomics Diagnostic Testing
  • Drug Metabolism & P450 effects
  • Others

DNA Diagnostics/Testing Regional Outlook (Revenue, USD Million, 2012 - 2022)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • Japan
    • China
  • Latin America
    • Brazil
    • Mexico
  • MEA
    • South Africa

Access full research report on global DNA testing market: 

http://www.grandviewresearch.com/industry-analysis/dna-testing-market

]]>